Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Phase III
Nanobiotix Receives First Approval To Start Phase 2/3 Registration Trial In Soft Tissue Sarcoma In Europe 10/16/2014 7:19:45 AM
Basilea Pharmaceutica (BSLN.SW) Reports Protocol Amendment Resulting In Earlier Completion Of Isavuconazole Phase 3 Invasive Candidiasis Study 10/16/2014 7:18:27 AM
PROMETHERA Biosciences S.A./N.V. Receives Approval In Belgium To Enroll Patients In The Imminent HEP002 Phase 2b/3 Clinical Trial 10/15/2014 9:48:05 AM
Peregrine Pharmaceuticals, Inc. (PPHM) Release: Data To Be Published In The Journal Of Immunology Research Support Phosphatidylserine (PS) As A Potential Target In Ebola Infection 10/15/2014 11:21:18 AM
Novartis AG (NVS)'s Secukinumab Has Consistent Activity In Psoriasis 10/13/2014 6:52:08 AM
Pacira Pharmaceuticals, Inc. (PCRX) Announces Additional Data Supporting Safety Of EXPAREL® In Peripheral Nerve Block 10/14/2014 8:37:48 AM
Noven Pharmaceuticals Inc. Announces Publication Of Exploratory Analyses From Pooled Phase 3 Results Of The Effects Of Brisdelle® (Paroxetine) Capsules On Weight And Sexual Function During Treatment Of Vasomotor Symptoms Associated With Menopause 10/14/2014 8:23:42 AM
Smith & Nephew plc (SNN)’s “Spray-On-Skin” For Leg Ulcers Flops In Trial 10/13/2014 6:03:00 AM
Cardio3 BioSciences Receives Authorization To Enroll Patients In Switzerland In Its Phase 3 Clinical Trial Chart-1 10/13/2014 11:37:20 AM
Ipsen (IPN.PA) Announces Positive Results From Phase III Clinical Study Of Decapeptyl® (triptorelin pamoate) 11.25 mg Administered By Subcutaneous Route To Prostate Cancer Patients 10/13/2014 11:02:52 AM
AbbVie (ABBV) Announces Late-Breaking Results From Phase 3 Trial Of HUMIRA® (Adalimumab) In Hidradenitis Suppurativa (HS) Patients At The European Academy Of Dermatology And Venereology Congress 10/13/2014 8:02:31 AM
Eisai Inc. (ESALF.PK) And Arena Pharmaceuticals, Inc. (ARNA) Announce Presentation Of Lorcaserin Hcl Data At The American College Of Clinical Pharmacy Annual Meeting 10/13/2014 7:38:28 AM
Isis Pharmaceuticals, Inc. (ISIS) Launches Key Trial Of Drug For Rare Spine Disorder 10/10/2014 6:15:24 AM
Eisai Inc. (ESALF.PK) And Arena Pharmaceuticals, Inc. (ARNA) Announce Publication Of Pooled Phase 3 Clinical Trial Analysis Of BELVIQ® (Lorcaserin Hcl) CIV In Postgraduate Medicine 10/10/2014 9:52:26 AM
AcelRx Pharmaceuticals (ACRX) Announces Multiple Sublingual Sufentanil Data Presentations At The American Society Of Anesthesiologists Meeting 10/10/2014 9:25:49 AM
1234567
//-->